المؤلفون: GwangPyo Ko, Won Kim, Seoyeon Park, Bon Jeong Ku, Sae Kyung Joo, Hyun Ju You, Jiyeon Si, Giljae Lee, Dong Hyeon Lee

المصدر: Computational and Structural Biotechnology Journal, Vol 19, Iss, Pp 5920-5930 (2021)
Computational and Structural Biotechnology Journal

مصطلحات موضوعية: endocrine system diseases, BMI, body mass index, Disease, Gut flora, Biochemistry, Gastroenterology, Structural Biology, LDL, low-density lipoprotein, Enterotype, biology, NASH-CRN, non-alcoholic steatohepatitis clinical research network, Fatty liver, Computer Science Applications, Cohort, LPS, lipopolysaccharide, Research Article, PICRUSt2, phylogenetic investigation of communities by reconstruction of unobserved states 2, Biotechnology, NAFLD, non-alcoholic fatty liver disease, medicine.medical_specialty, FDR, false discovery rate, NASH, non-alcoholic steatohepatitis, Biophysics, HbA1c, glycosylated hemoglobin, digestive system, MaAsLin2, microbiome multivariable association with linear models 2, Non-alcoholic fatty liver disease (NAFLD), ALT, alanine aminotransferase, Diabetes mellitus, Internal medicine, T2D, type 2 diabetes mellitus, Type 2 diabetes mellitus, Genetics, medicine, NAFL, non-alcoholic fatty liver, Microbiome, FBS, fasting blood sugar, ComputingMethodologies_COMPUTERGRAPHICS, Gut microbiome, business.industry, Type 2 Diabetes Mellitus, nutritional and metabolic diseases, Biomarker, medicine.disease, biology.organism_classification, digestive system diseases, business, FLI, fatty liver index, TP248.13-248.65

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f954c67889fd6d23e7de29c2b7336727Test
http://www.sciencedirect.com/science/article/pii/S2001037021004542Test

المؤلفون: Lea Ladegaard Grønkjær, Mette Munk Lauridsen

المصدر: JHEP Reports, Vol 3, Iss 6, Pp 100370-(2021)
Grønkjær, L L & Lauridsen, M M 2021, ' Quality of life and unmet needs in patients with chronic liver disease : A mixed-method systematic review ', JHEP Reports, vol. 3, no. 6, 100370 . https://doi.org/10.1016/j.jhepr.2021.100370Test
JHEP Reports

مصطلحات موضوعية: PBC, Primary Biliary Cholangitis Questionnaire, Patient experience, Quality of life, medicine.medical_specialty, NAFLD, non-alcoholic fatty liver disease, NASH, non-alcoholic steatohepatitis, VAS, visual analogue scale, Population, EQ-5D, European Quality of Life, FACT-Hep, Functional Assessment of Cancer Therapy Hepatobiliary Carcinoma, HBQOL, Hepatitis B Quality of Life, Disease, CINAHL, RC799-869, Chronic liver disease, SIP, Sickness Impact Profile, Unmet needs, MELD, model for end-stage liver disease, Liver disease, CLDQ, Chronic Liver Disease Questionnaire, LC-PROM, Liver Cirrhosis Patient Reported Outcome Measure, Quality of life (healthcare), Internal Medicine, medicine, Immunology and Allergy, Intensive care medicine, education, PedsQL, Pediatric Quality of Life Inventory, Patient reported outcomes, education.field_of_study, Hepatology, WHOQOL-BREF, WHO Quality of Life, business.industry, JBI, Joanna Briggs Institute, Gastroenterology, Diseases of the digestive system. Gastroenterology, medicine.disease, SF, Short Form, Mixed method, Systematic review, business, HCC, hepatocellular carcinoma, Research Article, LDQOL, Liver Disease Quality of Life

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5347f777d34d635854930477dc42eccfTest
http://www.sciencedirect.com/science/article/pii/S2589555921001464Test

المؤلفون: Pirouz Samidoust, Mohammad Taghi Ashoobi, R. Navid Talemi, M.S. Esmaeili Delshad, K. Mojtahedi, Aryan Samidoust, S. Jahangiri

المصدر: New Microbes and New Infections, Vol 44, Iss, Pp 100935-(2021)
New Microbes and New Infections

مصطلحات موضوعية: medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), medicine.medical_treatment, AST, aspartate aminotransferase, Disease, Infectious and parasitic diseases, RC109-216, Liver transplantation, Iran, SARS-CoV-2, severe acute respiratory syndrome coronavirus 2, Microbiology, ACE2, angiotensin-converting enzyme-2, Internal medicine, medicine, HDL, High-density lipoprotein, liver transplant recipients, DBIL, direct bilirubin, CTscan, computed tomography scan, CDC, Centers for Disease Control, In patient, TBIL, total bilirubin, NSAIDs, nonsteroidal anti-inflammatory drugs, HBV, Hepatitis B, NASH, Non-alcoholic steatohepatitis, Liver injury, liver transplantation, business.industry, SARS-CoV-2, Incidence (epidemiology), COVID-19, Retrospective cohort study, medicine.disease, PSC, primary sclerosing cholangitis, Infectious Diseases, Original Article, SD, standard deviation, business, TBIL

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::990cdcfd9e698bf3a0e2b7d10e9e6b75Test
http://www.sciencedirect.com/science/article/pii/S2052297521000998Test

المؤلفون: Valentin A. Pavlov

المصدر: Pharmacology & Therapeutics

مصطلحات موضوعية: 0301 basic medicine, ChAT, choline acetyltransferase, BMI, body mass index, Inflammatory reflex, NLRP3, NLRs nucleotide-binding oligomerization domain (NOD)-like receptors nucleotide-binding oligomerization domain-like receptor family pyrin domain containing-3, Type 2 diabetes, Disease, Bioinformatics, 0302 clinical medicine, AChE, acetylcholinesterase, Medicine, Pharmacology (medical), TLR, toll-like receptors, NF-κB, nuclear factor kappa B, COVID-19, coronavirus disease 2019, TNF, tumor necrosis factor, IBD, inflammatory bowel disease, HDL-C, high density lipoprotein-cholesterol, Vagus Nerve, GI, gastrointestinal, Metabolic syndrome, ICU, intensive care unit, Bioelectronic medicine, VNS, vagus nerve stimulation, 030220 oncology & carcinogenesis, LPS, lipopolysaccharide, MetS, metabolic syndrome, medicine.symptom, SARS-CoV, severe acute respiratory syndrome CoV, NAFLD, non-alcoholic fatty liver disease, NASH, non-alcoholic steatohepatitis, α7nAChR, alpha 7 nicotinic acetylcholine receptor, Inflammation, HRV, heart rate variability, Article, 03 medical and health sciences, NTS, nucleus tractus solitarius, Immune system, DMN, dorsal motor nucleus of the vagus, Humans, Obesity, mAChR, muscarinic acetylcholine receptor, ARDS, acute respiratory distress syndrome, Pharmacology, SARS-CoV-2, ACh, acetylcholine, business.industry, COVID-19, medicine.disease, NA, nucleus ambiguus, IL, interleukin, Vagus nerve, The inflammatory reflex, 030104 developmental biology, MERS-CoV, Middle East respiratory syndrome corona virus, JAK2/STAT3, Janus kinase 2/signal transducer and activator of transcription 3, business, SARS-CoV-2, severe acute respiratory syndrome coronavirus-2

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2e3679f48f885bb324216f0c362acfbTest

المؤلفون: Shira Zelber-Sagi, Rebecca Dorner, Giulio Marchesini, Marko Korenjak, Christos Lionis, Jeffrey V. Lazarus, Sven Francque, Achim Kautz, Luca Busetto, José Willemse, G. Koek, Dror Dicker, Kate Hallsworth, Shlomo Vinker, Gema Frühbeck, Euan Woodward, Mehmet Ungan, Juan M. Mendive, Martine Walmsley

المساهمون: Francque, Sven M, Marchesini, Giulio, Kautz, Achim, Walmsley, Martine, Dorner, Rebecca, Lazarus, Jeffrey V, Zelber-Sagi, Shira, Hallsworth, Kate, Busetto, Luca, Frühbeck, Gema, Dicker, Dror, Woodward, Euan, Korenjak, Marko, Willemse, José, Koek, Gerardus H, Vinker, Shlomo, Ungan, Mehmet, Mendive, Juan M, Lionis, Christos, Interne Geneeskunde, MUMC+: MA Maag Darm Lever (9), RS: NUTRIM - R2 - Liver and digestive health

المصدر: JHEP Reports
JHEP Reports, Vol 3, Iss 5, Pp 100322-(2021)
JHEP Reports, 3(5):100322. Elsevier BV

مصطلحات موضوعية: NASH, non-alcoholic steatohepatiti, Y GASTRIC BYPASS, Disease, RC799-869, PLACEBO-CONTROLLED TRIAL, LIFE-STYLE MODIFICATION, cardiovascular disease, LDL, low-density lipoprotein, HEPATOCELLULAR-CARCINOMA, non-invasive test, T2D, GLP-1 RAs, glucagon-like receptor 1 agonists, European Association for the Study of Obesity, HCC, Gastroenterology, NASH, specific, Diseases of the digestive system. Gastroenterology, CAP, controlled attenuation parameter, CT, computed tomography, FXR, ASH, alcoholic steatohepatitis, GP, non-alcoholic steatohepatitis, GLP-1 RAs, glucagon-like receptor 1 agonist, LDL, low-density lipoproteins, medicine.medical_specialty, HDL, achievable, NASH, non-alcoholic steatohepatitis, T2D, type 2 diabetes, high-density lipoprotein, CVD, cardiovascular disease, LDL, Patient Guideline, Quality of life (healthcare), FXR, farnesoid X receptor, NAFLD, low-density lipoproteins, GP, general practitioner, NAFL, non-alcoholic fatty liver, FIB-4, fibrosis-4 index, Intensive care medicine, computed tomography, Guideline, medicine.disease, T1D, type 1 diabete, digestive system diseases, NIT, Human medicine, farnesoid X receptor, type 1 diabetes, BMI, body mass index, EASL, European Association for the Study of the Liver, Placebo-controlled study, Chronic liver disease, GLP-1 RAs, QUALITY-OF-LIFE, alcoholic steatohepatitis, European Association for the Study of Diabetes, EASD, European Association for the Study of Diabetes, Immunology and Allergy, magnetic resonance imaging, NASH Clinical Research Network, ALD, alcohol-related or alcoholic liver disease, Disease management (health), glucagon-like receptor 1 agonists, EASO, European Association for the Study of Obesity, NASH CRN, NASH Clinical Research Network, ASH, alcoholic steatohepatiti, Fatty liver, timely, hepatocellular carcinoma, CVD, magnetic resonance elastography, MRE, NAFL, FIB-4, non-alcoholic fatty liver, type 2 diabetes, T1D, type 1 diabetes, CAP, controlled attenuation parameter, CT, European Association for the Study of the Liver, MRI, fibrosis-4 index, NAFLD, non-alcoholic fatty liver disease, EASD, HDL, high-density lipoprotein, UNITED-STATES, ASH, body mass index, EASL, measurable, BMI, NIT, non-invasive test, Internal Medicine, medicine, NASH CRN, HEPATIC STEATOSIS, HCC, hepatocellular carcinoma, MRE, magnetic resonance elastography, MRI, magnetic resonance imaging, SMART, specific, measurable, achievable, relevant, timely, Disease burden, BARIATRIC SURGERY, Hepatology, SMART, business.industry, SERUM ALANINE AMINOTRANSFERASE, non-alcoholic fatty liver disease, PHYSICAL-ACTIVITY, alcohol-related or alcoholic liver disease, EASD, European Association for the Study of Diabete, EASO, ALD, general practitioner, relevant, T1D, business

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc5e84bfe19b52d5e0324b299615b0e1Test
https://pubmed.ncbi.nlm.nih.gov/34693236Test

المؤلفون: Lucia Parlati, Catherine Postic, Marion Régnier, Hervé Guillou

المساهمون: LESUR, Hélène, Impact du métabolisme des acides gras des tissus adipeux et du foie sur l'insulinorésistance - - HepAdialogue2017 - ANR-17-CE14-0015 - AAPG2017 - VALID, Institut Cochin (IC UM3 (UMR 8104 / U1016)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Catholique de Louvain = Catholic University of Louvain (UCL), ToxAlim (ToxAlim), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Ecole Nationale Vétérinaire de Toulouse (ENVT), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Ecole d'Ingénieurs de Purpan (INPT - EI Purpan), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Toxicologie Intégrative & Métabolisme (ToxAlim-TIM), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Toulouse III - Paul Sabatier (UT3), Lucia Parlati and Catherine Postic received funding from the French association for the study of the liver (AFEF). Catherine Postic and Herve Guillou received funding from the Agence Nationale de la Recherche (ANR-17-CE14-0015Hepadialogue)., ANR-17-CE14-0015,HepAdialogue,Impact du métabolisme des acides gras des tissus adipeux et du foie sur l'insulinorésistance(2017), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP)

المصدر: JHEP Reports
JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, 2021, 3 (6), pp.100346. ⟨10.1016/j.jhepr.2021.100346⟩
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (6), pp.100346. ⟨10.1016/j.jhepr.2021.100346⟩

مصطلحات موضوعية: HFD, high-fat diet, SREBP-1c, [SDV]Life Sciences [q-bio], Disease, Review, ACC, acetyl-CoA carboxylase, ASK1, apoptosis signal-regulating kinase 1, Chronic liver disease, Bioinformatics, ChREBP, carbohydrate responsive element–binding protein, PPARα, NEFA, TNF-α, tumour necrosis factor-α, 0302 clinical medicine, Fibrosis, Immunology and Allergy, Medicine, IL-, interleukin, VLDL, very low-density lipoprotein, 0303 health sciences, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, NEFA, non-esterified fatty acid, Fatty liver, Gastroenterology, NASH, lipotoxicity, FAS, fatty acid synthase, animal models, 3. Good health, [SDV] Life Sciences [q-bio], PY, persons/years, Lipotoxicity, FXR, Saturated fatty acid, JNK, c-Jun N-terminal kinase, 030211 gastroenterology & hepatology, LXR, CAP, controlled attenuation parameter, HSL, hormone-sensitive lipase, HSC, hepatic stellate cells, GGT, gamma glutamyltransferase, NAFLD, non-alcoholic fatty liver disease, ChREBP, NASH, non-alcoholic steatohepatitis, SFA, saturated fatty acid, TCA, tricarboxylic acid, Phf2, histone demethylase plant homeodomain finger 2, digestive system, 03 medical and health sciences, glucotoxicity, FXR, farnesoid X receptor, NAFLD, FFA, free fatty acid, Internal Medicine, RCT, randomised controlled trial, Liver X receptor, PPARa, 030304 developmental biology, FGF21, fibroblast growth factor-21, MCD, methionine- and choline-deficient, HVPG, hepatic venous pressure gradient, Hepatology, business.industry, PUFAs, polyunsaturated fatty acids, nutritional and metabolic diseases, TLR4, Toll-like receptor 4, SCD1, stearoyl-CoA desaturase-1, medicine.disease, digestive system diseases, PPARα, peroxisome proliferator-activated receptor-α, SREBP-1c, sterol regulatory element–binding protein-1c, Steatosis, LXR, liver X receptor, business, HCC, hepatocellular carcinoma, MUFA, monounsaturated fatty acids, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba31673956635c337dc60791ff712432Test
https://pubmed.ncbi.nlm.nih.gov/34667947Test

المؤلفون: Manuel Romero-Gómez, Patrizia Carrieri, Mattias Ekstedt, Shira Zelber-Sagi, Katja Novak, Vlad Ratziu, Quentin M. Anstee, Frank Tacke, Adam Palayew, Jeffrey V. Lazarus, Helena Cortez-Pinto, Giulio Marchesini

المساهمون: Instituto de Salud Global - Institute For Global Health [Barcelona] (ISGlobal), University of Barcelona, McGill University = Université McGill [Montréal, Canada], Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Linköping University (LIU), Alma Mater Studiorum University of Bologna (UNIBO), Istituto di ricovero e cura a carattere scientifico Azienda Ospedaliera Universitaria 'San Martino' (IRCCS AOU San Martino), University Medical Centre Ljubljana [Ljubljana, Slovenia] (UMCL), Sorbonne Université - Faculté de Médecine (SU FM), Sorbonne Université (SU), CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas (CIBERehd), Liver Unit, Clínica Universitaria, CIBER-EHD, Hospital Universitario Virgen del Rocío [Sevilla], Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], University of Haifa [Haifa], Universidade de Lisboa (ULISBOA), Newcastle University [Newcastle], Lazarus J.V., Palayew A., Carrieri P., Ekstedt M., Marchesini G., Novak K., Ratziu V., Romero-Gomez M., Tacke F., Zelber-Sagi S., Cortez-Pinto H., Anstee Q.M., EASL International Liver Foundation, Gilead Sciences, Allergan Foundation, Bristol-Myers Squibb, Pfizer, Resoundant, Intercept Pharmaceuticals, Genfit, Ministerio de Ciencia, Innovación y Universidades (España), Instituto de Salud Carlos III, European Commission, Generalitat de Catalunya, NIHR Biomedical Research Centre (UK), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Universidade de Lisboa = University of Lisbon (ULISBOA), Repositório da Universidade de Lisboa, Gestionnaire, Hal Sorbonne Université

المصدر: JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (2), pp.100234. ⟨10.1016/j.jhepr.2021.100234⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
JHEP Reports
JHEP Reports, Vol 3, Iss 2, Pp 100234-(2021)

مصطلحات موضوعية: ESPEN, type 2 diabetes mellitus, EASL, European Association for the Study of the Liver, [SDV]Life Sciences [q-bio], Disease, Multiple joint correspondence analysi, WHO, 0302 clinical medicine, Non-alcoholic fatty liver disease, Liver health, Multiple joint correspondence analysis, Policy preparedness, Health policy, Metabolic-associated fatty liver disease, Non-alcoholic steatohepatitis, Europe, Multidisciplinary approach, EASD, European Association for the Study of Diabetes, European Association for the Study of Diabetes, Epidemiology, Immunology and Allergy, Medicine, European Association for the Study of Obesity, European Society of Clinical Nutrition and Metabolism, EEA, EASO, European Association for the Study of Obesity, media_common, Gastroenterology, NASH, food and beverages, ESPEN, European Society of Clinical Nutrition and Metabolism, 3. Good health, [SDV] Life Sciences [q-bio], 030220 oncology & carcinogenesis, Preparedness, 030211 gastroenterology & hepatology, Research Article, European Association for the Study of the Liver, EEA, European Economic Area, medicine.medical_specialty, NAFLD, non-alcoholic fatty liver disease, EASD, NASH, non-alcoholic steatohepatitis, multiple correspondence analysis, T2DM, Gastroenterology and Hepatology, EASL, World Health Organization, digestive system, WHO, World Health Organization, European Economic Area, 03 medical and health sciences, Environmental health, EU, European Union, NAFLD, Gastroenterologi, Internal Medicine, media_common.cataloged_instance, European Union, lcsh:RC799-869, European union, MCA, multiple correspondence analysis, Hepatology, business.industry, Public health, MCA, nutritional and metabolic diseases, non-alcoholic fatty liver disease, T2DM, type 2 diabetes mellitus, medicine.disease, Obesity, digestive system diseases, EASO, lcsh:Diseases of the digestive system. Gastroenterology, business, EU, Non-alcoholic steatohepatiti

وصف الملف: ELETTRONICO; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::237265ca3a905978c88b2731dd069191Test
https://hal.sorbonne-universite.fr/hal-03174867Test

المؤلفون: Linda Henry, Zobair M. Younossi

المصدر: JHEP Reports

مصطلحات موضوعية: medicine.medical_specialty, NAFLD, non-alcoholic fatty liver disease, Cirrhosis, STAT3, signal transducer and activator of transcription 3, NASH, non-alcoholic steatohepatitis, Context (language use), Disease, Type 2 diabetes, Review, CVD, cardiovascular disease, Gastroenterology, digestive system, ELF, enhanced liver fibrosis, PDGF, platelet-derived growth factor, Internal medicine, Epidemiology, Internal Medicine, Immunology and Allergy, Medicine, awareness, FIB-4, fibrosis-4, ALD, alcohol-related liver disease, neoplasms, Hepatology, business.industry, cirrhosis, Fatty liver, nutritional and metabolic diseases, non-cirrhosis, medicine.disease, Obesity, VEGF, vascular endothelial growth factor, digestive system diseases, natural history, Hepatocellular carcinoma, surveillance, business, HCC, hepatocellular carcinoma, TNF, tumour necrosis factor-α

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48a4964dc0d86470071e38394d6df7fbTest
https://pubmed.ncbi.nlm.nih.gov/34189448Test

المؤلفون: Daniel G.K. Rasmussen, Peder Frederiksen, Diana Julie Leeming, Lise Lotte Gluud, Elisabeth Erhardtsen, Jörn M. Schattenberg, Diane E. Shevell, M.A. Karsdal, Guruprasad P. Aithal

المصدر: Erhardtsen, E, Rasmussen, D G K, Frederiksen, P, Leeming, D J, Shevell, D, Gluud, L L, Karsdal, M A, Aithal, G P & Schattenberg, J M 2021, ' Determining a healthy reference range and factors potentially influencing PRO-C3 – A biomarker of liver fibrosis ', JHEP Reports, vol. 3, no. 4, 100317 . https://doi.org/10.1016/j.jhepr.2021.100317Test
JHEP Reports, Vol 3, Iss 4, Pp 100317-(2021)
JHEP Reports

مصطلحات موضوعية: NASH-CRN, NASH Clinical Research Network, Biopsy, Disease, AST, aspartate aminotransferase, RC799-869, Ethnic groups, Gastroenterology, NIMBLE, Non-Invasive Biomarkers of Metabolic Liver Disease (consortium), Fibrosis, Immunology and Allergy, Body mass index, medicine.diagnostic_test, Fatty liver, NAS, NAFLD Activity Score, Diseases of the digestive system. Gastroenterology, Hospitals, NPV, negative predictive value, Liver biopsy, Biomarker (medicine), Research Article, medicine.medical_specialty, NAFLD, non-alcoholic fatty liver disease, ADAM, A Disintegrin and Metalloproteases, NASH, non-alcoholic steatohepatitis, Reference range, Reference values, AUROC, area under the receiver operating characteristics curve, Internal medicine, ALT, alanine aminotransferase, Internal Medicine, medicine, Humans, FIB-4, fibrosis-4, Healthy volunteers, Hepatology, ALP, alkaline phosphatase, business.industry, CLSI, Clinical and Laboratory Standards Institute, T2DM, type 2 diabetes mellitus, ELF™ test, Enhanced Liver Fibrosis test, medicine.disease, LITMUS, Liver Investigation: Testing Marker Utility in Steatohepatitis (consortium), Collagen type III, PPV, positive predictive value, Reference standards, business, Biomarkers, Non-alcoholic fatty liver disease

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d4eefdc7b3714522d884aabf5fb9f2cTest
https://curis.ku.dk/portal/da/publications/determining-a-healthy-reference-range-and-factors-potentially-influencing-proc3--a-biomarker-of-liver-fibrosisTest(c941fd32-bad0-4d92-b259-f5dc9c239ed9).html

المؤلفون: Syed Tasleem, Umar Hayat, Saba Afroz, Ahmed Haris, Hayrettin Okut, Ali A. Siddiqui

المصدر: Annals of Hepatology, Vol 20, Iss, Pp 100254-(2021)

مصطلحات موضوعية: Liver Cirrhosis, medicine.medical_specialty, Specialties of internal medicine, Drinking Behavior, Disease, Chronic liver disease, Gastroenterology, NAFLD (non-alcoholic fatty liver disease), Coffee, NASH (Non-alcoholic steatohepatitis), 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Non-alcoholic Fatty Liver Disease, Internal medicine, Caffeine, Epidemiology, medicine, Humans, Hepatology, business.industry, Fatty liver, Confidence interval, nutritional and metabolic diseases, General Medicine, medicine.disease, digestive system diseases, Relative risk, chemistry, RC581-951, 030220 oncology & carcinogenesis, Meta-analysis, 030211 gastroenterology & hepatology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9db1203a30b676744792d706528112a5Test
https://pubmed.ncbi.nlm.nih.gov/32920163Test